Literature DB >> 26099554

Chronic Thromboembolic Pulmonary Hypertension: the End Result of Pulmonary Embolism.

Alison S Witkin1, Richard N Channick.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) occurs when a pulmonary embolism fails to undergo complete thrombolysis leading to vascular occlusion and pulmonary hypertension. Despite the fact that CTEPH is a potential consequence of pulmonary embolism, diagnosis requires a high degree of vigilance as many patients will not have a history of thromboembolic disease. The ventilation perfusion scan is used to evaluate for the possibility of CTEPH although right heart catheterization and pulmonary artery angiogram are needed to confirm the diagnosis. Pulmonary thromboendarterectomy is the first-line treatment for patients who are surgical candidates. Recently, riociguat has been approved for patients with nonsurgical disease or residual pulmonary hypertension despite surgical intervention. This review describes the pathophysiology, risk factors, diagnosis, and management of CTEPH.

Entities:  

Mesh:

Year:  2015        PMID: 26099554     DOI: 10.1007/s11886-015-0621-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  61 in total

Review 1.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

2.  Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients.

Authors:  Michael M Madani; William R Auger; Victor Pretorius; Naohide Sakakibara; Kim M Kerr; Nick H Kim; Peter F Fedullo; Stuart W Jamieson
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

3.  The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.

Authors:  K M McIntyre; A A Sasahara
Journal:  Am J Cardiol       Date:  1971-09       Impact factor: 2.778

4.  Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism.

Authors:  Ugur Coskun; Umit Yasar Sinan; Ilknur Calpar; Bedrettin Yildizeli; Mehmet Yanartas; Deniz Filinte; Mehmet Serdar Kucukoglu
Journal:  Tex Heart Inst J       Date:  2014-10-01

Review 5.  Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review.

Authors:  Mathilde Nijkeuter; Marcel M C Hovens; Bruce L Davidson; Menno V Huisman
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

6.  Bronchial artery dilatation on MDCT scans of patients with acute pulmonary embolism: comparison with chronic or recurrent pulmonary embolism.

Authors:  Ichiro Hasegawa; Phillip M Boiselle; Hiroto Hatabu
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

7.  Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism.

Authors:  Misako Iino; Steven Dymarkowski; Lertlak Chaothawee; Marion Delcroix; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-12-20       Impact factor: 5.315

8.  Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography.

Authors:  Angela Reichelt; Marius M Hoeper; Michael Galanski; Marc Keberle
Journal:  Eur J Radiol       Date:  2008-05-06       Impact factor: 3.528

9.  Predictors of outcome in chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Nika Skoro-Sajer; Johannes Jakowitsch; Christopher Adlbrecht; Daniela Dunkler; Sharokh Taghavi; Walter Klepetko; Meinhard Kneussl; Irene M Lang
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

10.  Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hiroki Mizoguchi; Aiko Ogawa; Mitsuru Munemasa; Hiroshi Mikouchi; Hiroshi Ito; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2012-11-27       Impact factor: 6.546

View more
  5 in total

Review 1.  From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.

Authors:  Andreas Friebe; Peter Sandner; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-10-20       Impact factor: 3.000

Review 2.  A narrative review of red blood cell distribution width as a marker for pulmonary embolism.

Authors:  Lindsay Hammons; Jason Filopei; David Steiger; Eric Bondarsky
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

3.  Quantifying the learning curve for pulmonary thromboendarterectomy.

Authors:  Smita Sihag; Bao Le; Alison S Witkin; Josanna M Rodriguez-Lopez; Mauricio A Villavicencio; Gus J Vlahakes; Richard N Channick; Cameron D Wright
Journal:  J Cardiothorac Surg       Date:  2017-12-28       Impact factor: 1.637

4.  Impact of Balloon Pulmonary Angioplasty on Hemodynamics and Clinical Outcomes in Patients with Chronic Thromboembolic Pulmonary Hypertension: the Initial Korean Experience.

Authors:  Woochan Kwon; Jeong Hoon Yang; Taek Kyu Park; Sung A Chang; Dong Seop Jung; Young Seok Cho; Sung Mok Kim; Tae Jung Kim; Hye Yoon Park; Seung Hyuk Choi; Duk Kyung Kim
Journal:  J Korean Med Sci       Date:  2018-01-22       Impact factor: 2.153

5.  Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment.

Authors:  Asako Yanagisawa; Akira Naito; Takayuki Jujo-Sanada; Nobuhiro Tanabe; Keiichi Ishida; Goro Matsumiya; Rika Suda; Hajime Kasai; Ayumi Sekine; Toshihiko Sugiura; Ayako Shigeta; Seiichiro Sakao; Koichiro Tatsumi; Takuji Suzuki
Journal:  BMC Pulm Med       Date:  2021-12-09       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.